The Form 4 filing, an SEC report of insider stock trades, was filed on October 27, 2026. The trades ran from October 23 through October 27. Clark Kyle is president and chief executive officer of BETA.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-23 |
| Date of Latest Transaction | 2026-10-27 |
| Buy/Sell | sell |
| Transaction Count | 3 |
| Shares Transacted | 30,000 |
| Price | $19.91 |
| Total Transaction Value | $597,247.00 |
| Insider | |
| Ticker Symbol | BETA |
| Company | BETA Technologies, Inc. |
| Insider Name | Clark Kyle |
| Insider Title | President and Chief Executive Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 4,995,936 |
| Position Size Change | 0.60% |
| Filing | |
| Filing Date | 2026-10-27 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under transaction code S. Three transactions were reported in one filing for one insider. The available details do not break out all three sales by size and date.
What was the average price of the transaction?
The average sale price was $19.91 per share, rounded to cents. This average covers all 30,000 shares sold in the three transactions. Separate prices for each sale are not available.
How did this transaction affect the insider's holdings?
Clark Kyle sold 30,000 shares and reported owning 4,995,936 shares afterward. The shares sold made up about 0.60% of the shares owned before the sales.
What's the total transaction value?
The three sales had a total reported value of $597,247.00. Individual values for each sale are not available.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text is unavailable, so it is unclear whether the reference covers all three sales or only some of them. The plan's terms, including its setup date and trading schedule, are also unknown.
For research purposes only; not investment advice.